0001209191-20-032003.txt : 20200526
0001209191-20-032003.hdr.sgml : 20200526
20200526162017
ACCESSION NUMBER: 0001209191-20-032003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200521
FILED AS OF DATE: 20200526
DATE AS OF CHANGE: 20200526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dolsten Mikael
CENTRAL INDEX KEY: 0001437590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 20910792
MAIL ADDRESS:
STREET 1: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-21
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001437590
Dolsten Mikael
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE
NEWTON
MA
02459
1
0
0
0
Nonstatutory Stock Option (right to buy)
19.11
2020-05-21
4
A
0
16400
0.00
A
2030-05-20
Common Stock
16400
16400
D
This option vests as to 100% of the underlying shares on May 21, 2021, provided that the reporting person continues to serve as a director of the issuer through such date.
/s/ Christopher B. Primiano, Attorney-in-Fact for Mikael Dolsten
2020-05-26